Bonn, 22 April 2026 – Until now, there have been few therapeutic options for children with severely reduced heart pump ...
Until now, there have been few therapeutic options for children with severely reduced heart pump function. Recently, surgical ...
Tirzepatide significantly reduces cardiovascular death or worsening heart failure risk by 38% in patients with obesity-related HFpEF. The drug improves blood pressure, inflammation, and volume ...
Patients with pre-existing high blood pressure are more likely to be susceptible to heart damage caused by anthracyclines, the most widely used chemotherapy drugs for cancer treatment for more than 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results